Lisata Therapeutics (LSTA) 10-K2019 FY Annual report

Filed: 5 Mar 20, 4:13pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: abetting, aiding, Bairey, Barbra, borrowing, Canadian, clarify, codification, codify, comment, content, context, corona, culminate, debarment, deliberate, DSCSA, embedded, evolution, FACC, FAHA, fatal, FESC, finely, fire, GDPR, Hubei, implicit, Instruction, landscape, mandated, manipulated, Merz, native, necessarily, networking, Noel, noncompliance, notion, outbreak, outdated, overly, PA, PDMA, Philadelphia, poised, postpone, preparatory, Province, Questionnaire, reassessed, residence, salable, score, Seattle, sensitive, simplify, Society, strain, Streisand, supplementary, teaching, trace, tuned, untreatable, variation, vessel, wholesale, Women, Wuhan

Removed: absent, acceleration, accredited, achieved, al, Allendale, allergic, Alliance, allocating, amortize, anniversary, antibody, ascertained, Asia, Aspire, assembled, assumed, attacked, Australia, beta, Bluestone, bowel, Capricor, Celyad, Centenary, commenced, compliant, confirmed, conjugated, creation, cumulative, CVC, dated, death, defer, delaying, deposited, disbursed, discontinued, effected, effector, EMA, employed, enhancing, escrow, eventually, expertise, Family, Francisco, functioning, GVHD, harmful, iii, imbalance, immunomodulation, improving, Inconsistent, indemnify, inflammatory, informing, insulin, IP, isolation, Jeffrey, kidney, launch, lifelong, magnetic, maximize, membership, Mesoblast, mistakenly, modulation, Mountain, NeoStem, noncancelable, NY, obstructive, onset, Oxford, pathologic, payable, PCT, platelet, Pluristem, polyclonal, positioned, President, Preti, preventing, proper, pulmonary, Pvt, Qizhi, Qualification, randomized, refundable, relationship, released, remained, rental, repaid, representation, represented, restoring, retention, rheumatoid, Robert, San, Sanford, science, segment, shift, SLE, Sosei, sourced, spent, split, subsidiary, sue, sugar, supplement, systemic, Tang, taxing, thirty, thought, translational, transplantation, treating, Treg, UCSF, unchecked, underway, University, unnatural, updated, venture, Vericel, worldwide

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated LSTA transcripts

LSTA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our report dated March 5, 2020, with respect to the consolidated financial statements included in the Annual Report of Caladrius Biosciences, Inc. on Form 10-K for the year ended December 31, 2019. We consent to the incorporation by reference of said report in the Registration Statements of Caladrius Biosciences, Inc. on Forms S-3 (File No. 333-196702, File No. 333-206175, File No. 333-210664, File No. 333-214607, File No. 333-220354, and File No. 333-226319) and on Forms S-8 (File No. 333-107438, File No. 333-144265, File No. 333-159282, File No. 333-162733, File No. 333-173854, File No. 333-181365, File No. 333- 184927, File No. 333-191572, File No. 333-205662, File No. 333-212202, File No. 333-215455, File No. 333-218642, File No. 333-222410, File No. 333-225743, and File No. 333-225744).

New York, New York

March 5, 2020